EKIVF yields 3.65% · MRK yields 2.76%● Live data
📍 EKIVF pulled ahead of the other in Year 1
Combined, EKIVF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EKIVF + MRK for your $10,000?
Enka Insaat ve Sanayi A.S., together with its subsidiaries, operates as a construction company in Turkey, Russia, Kazakhstan, Georgia, Iraq, and internationally. It operates through four segments: Construction, Rental, Energy, and Trading and Manufacturing. The company engages in the construction of industrial and social buildings, and motorways; construction and operation of natural gas fired electrical energy generation facilities; and investment in and development of real estate properties and shopping malls. It is also involved in the marketing and after-sale service of construction machineries, trucks, industrial products, and spare parts; manufacturing of structural steel works; installation and establishment of the technical equipment; and excavation backfilling works and quarrying crushing operation of highway projects. In addition, the company engages in the pile dwelling work; base and superstructure construction; slip form and construction of drilling and ground surveys; organization of conventions and seminars; tour reservations and tickets sales; production of ready-mixed concrete; production and sale of electricity; repair and maintenance of power plants; and provision of architectural design and air transportation services, as well as trading activities. Further, it is involved in various activities, such as material handling and storage systems, auxiliary facilities, water treatment and environmental engineering, infrastructure and construction, control systems, and instrumentation engineering activities. Enka Insaat ve Sanayi A.S. was incorporated in 1957 and is headquartered in Istanbul, Turkey.
Full EKIVF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.